GlaxoSmithKline’s Quarterly Revenue Trend and Estimates

GlaxoSmithKline (GSK) reported revenue of ~7.2 billion British pounds in the first quarter, a 2% fall compared to the ~7.3 billion pounds it reported during the first quarter of 2017. Its revenue included a 4% rise in operating revenue, which was more than offset by the 6% negative impact of foreign exchange during the quarter. GlaxoSmithKline reports its revenues under three business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.